Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan 20;131(2):137-143.
doi: 10.4103/0366-6999.222343.

Early Neurological Deterioration after Recanalization Treatment in Patients with Acute Ischemic Stroke: A Retrospective Study

Ying-Bo Zhang  1 , Ying-Ying Su  1 , Yan-Bo He  1 , Yi-Fei Liu  1 , Gang Liu  1 , Lin-Lin Fan  1
Affiliations

Early Neurological Deterioration after Recanalization Treatment in Patients with Acute Ischemic Stroke: A Retrospective Study

Ying-Bo Zhang et al. Chin Med J (Engl). .

Abstract

Background: Early neurological deterioration (END) is a prominent issue after recanalization treatment. However, few studies have reported the characteristics of END after endovascular treatment (EVT) as so far. This study investigated the incidence, composition, and outcomes of END after intravenous recombinant tissue plasminogen activator (IV rt-PA) and EVT of acute ischemic stroke, and identified risk factors for END.

Methods: Medical records of patients who received recanalization treatment between January 1, 2014, and December 31, 2015 were reviewed. Patients were classified into IV rt-PA or EVT group according to the methods of recanalization treatment. The END was defined as an increase in the National Institutes of Health Stroke Scale (NIHSS) ≥4 or an increase in Ia of NIHSS ≥1 within 72 h after recanalization treatment. Clinical data were compared between the END and non-END subgroups within each recanalization group.

Results: Of the 278 patients included in the study, the incidence of END was 34.2%. The incidence rates of END were 29.8% in the IV rt-PA group and 40.2% in the EVT group. Ischemia progression (68.4%) was the main contributor to END followed by vasogenic cerebral edema (21.1%) and symptomatic intracranial hemorrhage (10.5%). Multivariate logistic regression showed that admission systolic blood pressure (SBP) ≥160 mmHg (odds ratio [OR]: 2.312, 95% confidence interval [CI]: 1.105-4.837) and large artery occlusion after IV rt-PA (OR: 3.628, 95% CI: 1.482-8.881) independently predicted END after IV rt-PA; and admission SBP ≥140 mmHg (OR: 5.183, 95% CI: 1.967-13.661), partial recanalization (OR: 4.791, 95% CI: 1.749-13.121), and nonrecanalization (OR: 5.952, 95% CI: 1.841-19.243) independently predicted END after EVT. The mortality rate and grave outcome rate at discharge of all the END patients (26.3% and 55.8%) were higher than those of all the non-END patients (1.1% and 18.6%; P < 0.01).

Conclusions: END was not an uncommon event and associated with death and grave outcome at discharge. High admission SBP and unsatisfactory recanalization of occluded arteries might predict END.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Flow chart of patient profile. RCT: Recanalization treatment; mRS: Modified Rankin Scale; IV rt-PA: Intravenous recombinant tissue plasminogen activator; EVT: Endovascular treatment; END: Early neurological deterioration.
Figure 2
Figure 2
Composition of END in all patients receiving recanalization treatment, the IV rt-PA group and the EVT group. END: Early neurological deterioration; IV rt-PA: Intravenous recombinant tissue plasminogen activator; EVT: Endovascular treatment; IS: Ischemia progression; VCE: Vasogenic cerebral edema; sICH: Symptomatic intracerebral hemorrhage.
Figure 3
Figure 3
The effect of IV rt-PA and EVT on each type of END. END: Early neurological deterioration; IV rt-PA: Intravenous recombinant tissue plasminogen activator; EVT: Endovascular treatment; IS: Ischemia progression; VCE: Vasogenic cerebral edema; sICH: Symptomatic intracerebral hemorrhage.
See this image and copyright information in PMC

References

    1. Seners P, Turc G, Oppenheim C, Baron JC. Incidence, causes and predictors of neurological deterioration occurring within 24 h following acute ischaemic stroke: A systematic review with pathophysiological implications. J Neurol Neurosurg Psychiatry. 2015;86:87–94. doi: 10.1136/jnnp-2014-308327. - PubMed
    1. Seners P, Turc G, Tisserand M, Legrand L, Labeyrie MA, Calvet D, et al. Unexplained early neurological deterioration after intravenous thrombolysis: Incidence, predictors, and associated factors. Stroke. 2014;45:2004–9. doi: 10.1161/STROKEAHA.114.005426. - PubMed
    1. Kim JM, Moon J, Ahn SW, Shin HW, Jung KH, Park KY, et al. The etiologies of early neurological deterioration after thrombolysis and risk factors of ischemia progression. J Stroke Cerebrovasc Dis. 2016;25:383–8. doi: 10.1016/j.jstrokecerebrovasdis.2015.10.010. - PubMed
    1. Jauch EC, Saver JL, Adams HP, Jr, Bruno A, Connors JJ, Demaerschalk BM, et al. Guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:870–947. doi: 10.1161/STR.0b013e318284056a. - PubMed
    1. Powers WJ, Derdeyn CP, Biller J, Coffey CS, Hoh BL, Jauch EC, et al. 2015 American Heart Association/American Stroke Association focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment: A Guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46:3020–35. doi: 10.1161/STR.0000000000000074. - PubMed

Substances

LinkOut - more resources